Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele

Por Virgili, Anna, Koptyra, Mateusz, Dasgupta, Yashodhara, Glodkowska-Mrowka, Eliza, Stoklosa, Tomasz, Nacheva, Elisabeth P., Skorski, Tomasz
Publicado em 2011

Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia

Por Slupianek, Artur, Dasgupta, Yashodhara, Ren, Shu-yue, Gurdek, Ewa, Donlin, Milene, Nieborowska-Skorska, Margaret, Fleury, Fabrice, Skorski, Tomasz
Publicado em 2011

Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases

Por Dasgupta, Yashodhara, Koptyra, Mateusz, Hoser, Grazyna, Kantekure, Kanchan, Roy, Darshan, Gornicka, Barbara, Nieborowska-Skorska, Margaret, Bolton-Gillespie, Elisabeth, Cerny-Reiterer, Sabine, Müschen, Markus, Valent, Peter, Wasik, Mariusz A., Richardson, Christine, Hantschel, Oliver, van der Kuip, Heiko, Stoklosa, Tomasz, Skorski, Tomasz
Publicado no Blood (2016)